/NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/ VICTORIA, BC — /CNW/ — Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX), a Phase 2 clinical-stage… Read More
Long time advocates for personal UV protection strategies, BC Cancer experts now leading advocacy on future planning of outdoor spaces. As climate change causes hotter, dryer conditions for months on… Read More
VANCOUVER, BC — Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF), (“Aequus” or the “Company”), a specialty pharmaceutical company announces the pause of sales of its Evolve Intensive eyedrop and Intensive gel… Read More
Some patients with early-stage, low-risk breast cancer may not need radiation therapy after breast conserving surgery, according to new research from the UBC faculty of medicine, BC Cancer, McMaster University… Read More
Minjuvi® (tafasitamab) is the first CD19 targeted immunotherapy option for patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL), addressing a significant unmet medical need This is the first public listing since… Read More
